SMINT: Stage 2 application FP7-HEALTH-13-INNOVATION-1. Novel targets for cardiovascular disease treatment.
Reference number | |
Coordinator | RED GLEAD DISCOVERY AB |
Funding from Vinnova | SEK 118 983 |
Project duration | December 2012 - February 2013 |
Status | Completed |